MedTrace Logo

Automated Oxygen Titration with O2matic Home Oxygen Therapy (O2matic HOT) Phase 1

NCT04606290 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-10-15

No results posted yet for this study

Summary

O2matic HOT is a further development of O2matic and is intended for home oxygen use with patients in need of long-term oxygen treatment (LTOT). O2matic HOT is a closed-loop system which on basis of signals from pulse oximetry titrates the oxygen flow to the patient. In this crossover trial patients are admitted for 24 hours twice. Once with usual fixed dose oxygen and once with oxygen titration by O2matic HOT.

Conditions

  • COPD
  • Chronic Hypoxemic Respiratory Failure

Interventions

DEVICE

O2matic HOT

Automated oxygen titration with O2matic HOT

DEVICE

Oxygen concentrator

Fixed dose oxygen flow from concentrator

Sponsors & Collaborators

  • Innovation Fund Denmark

    collaborator INDIV

  • Naestved Hospital

    collaborator OTHER

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Thomas Ringbaek, PhD · Hvidovre University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-28
Primary Completion
2023-07-01
Completion
2023-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04606290 on ClinicalTrials.gov